Retroperitoneal fibrosis associated with atenolol.
D001262:Atenolol / Q000009:adverse effects*; D001799:Blood Sedimentation; D006801:Humans; D010096:Oxprenolol / Q000009:adverse effects; D011217:Practolol / Q000009:adverse effects; D011412:Propanolamines / Q000009:adverse effects*; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced*
D011412:Propanolamines; D001262:Atenolol; D010096:Oxprenolol; D011217:Practolol